BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27291835)

  • 41. Lack of acidic fibroblast growth factor activation by heparan sulfate species from diabetic rat skin.
    Bourin MC
    Glycoconj J; 1997 Jun; 14(4):423-32. PubMed ID: 9249139
    [TBL] [Abstract][Full Text] [Related]  

  • 42. FGF2 binding, signaling, and angiogenesis are modulated by heparanase in metastatic melanoma cells.
    Reiland J; Kempf D; Roy M; Denkins Y; Marchetti D
    Neoplasia; 2006 Jul; 8(7):596-606. PubMed ID: 16867222
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sulfated glycosaminoglycans mediate the effects of FGF2 on the osteogenic potential of rat calvarial osteoprogenitor cells.
    Ling L; Murali S; Dombrowski C; Haupt LM; Stein GS; van Wijnen AJ; Nurcombe V; Cool SM
    J Cell Physiol; 2006 Dec; 209(3):811-25. PubMed ID: 16972247
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structural specificity in a FGF7-affinity purified heparin octasaccharide required for formation of a complex with FGF7 and FGFR2IIIb.
    Luo Y; Ye S; Kan M; McKeehan WL
    J Cell Biochem; 2006 Apr; 97(6):1241-58. PubMed ID: 16315317
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endothelial and fibroblast cell-derived heparan sulphate bind with differing affinity to basic fibroblast growth factor.
    Pye DA; Kumar S
    Biochem Biophys Res Commun; 1998 Jul; 248(3):889-95. PubMed ID: 9704022
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Heparan sulfate 6-O-endosulfatases: discrete in vivo activities and functional co-operativity.
    Lamanna WC; Baldwin RJ; Padva M; Kalus I; Ten Dam G; van Kuppevelt TH; Gallagher JT; von Figura K; Dierks T; Merry CL
    Biochem J; 2006 Nov; 400(1):63-73. PubMed ID: 16901266
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential regulation of FGF-1 and -2 mitogenic activity is related to their kinetics of binding to heparan sulfate in MDA-MB-231 human breast cancer cells.
    Fernig DG; Chen HL; Rahmoune H; Descamps S; Boilly B; Hondermarck H
    Biochem Biophys Res Commun; 2000 Jan; 267(3):770-6. PubMed ID: 10673367
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fibroblast Growth Factor 2 Protein Stability Provides Decreased Dependence on Heparin for Induction of FGFR Signaling and Alters ERK Signaling Dynamics.
    Koledova Z; Sumbal J; Rabata A; de La Bourdonnaye G; Chaloupkova R; Hrdlickova B; Damborsky J; Stepankova V
    Front Cell Dev Biol; 2019; 7():331. PubMed ID: 31921844
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fibroblast growth factor 2 inhibits bone morphogenetic protein 9-induced osteogenic differentiation of mesenchymal stem cells by repressing Smads signaling and subsequently reducing Smads dependent up-regulation of ALK1 and ALK2.
    Song T; Wang W; Xu J; Zhao D; Dong Q; Li L; Yang X; Duan X; Liang Y; Xiao Y; Wang J; He J; Tang M; Wang J; Luo J
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1639-46. PubMed ID: 23680673
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The influence of fibroblast growth factor 2 on the senescence of human adipose-derived mesenchymal stem cells during long-term culture.
    Cheng Y; Lin KH; Young TH; Cheng NC
    Stem Cells Transl Med; 2020 Apr; 9(4):518-530. PubMed ID: 31840944
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modulation of microvascular signaling by heparan sulfate matrix: studies in syndecan-4 transgenic mice.
    Li J; Partovian C; Li J; Hampton TG; Metais C; Tkachenko E; Sellke FW; Simons M
    Microvasc Res; 2002 Jul; 64(1):38-46. PubMed ID: 12074629
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A novel agonist with homobivalent single-domain antibodies that bind the FGF receptor 1 domain III functions as an FGF2 ligand.
    Yonehara R; Kumachi S; Kashiwagi K; Wakabayashi-Nakao K; Motohashi M; Murakami T; Yanagisawa T; Arai H; Murakami A; Ueno Y; Nemoto N; Tsuchiya M
    J Biol Chem; 2023 Feb; 299(2):102804. PubMed ID: 36529290
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Is the sensitivity of cells for FGF-1 and FGF-2 regulated by cell surface heparan sulfate proteoglycans?
    Zhou FY; Owens RT; Hermonen J; Jalkanen M; Höök M
    Eur J Cell Biol; 1997 Jun; 73(2):166-74. PubMed ID: 9208230
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The calcium-binding type III repeats domain of thrombospondin-2 binds to fibroblast growth factor 2 (FGF2).
    Rusnati M; Borsotti P; Moroni E; Foglieni C; Chiodelli P; Carminati L; Pinessi D; Annis DS; Paiardi G; Bugatti A; Gori A; Longhi R; Belotti D; Mosher DF; Colombo G; Taraboletti G
    Angiogenesis; 2019 Feb; 22(1):133-144. PubMed ID: 30168023
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evidence that heparin saccharides promote FGF2 mitogenesis through two distinct mechanisms.
    Goodger SJ; Robinson CJ; Murphy KJ; Gasiunas N; Harmer NJ; Blundell TL; Pye DA; Gallagher JT
    J Biol Chem; 2008 May; 283(19):13001-8. PubMed ID: 18281281
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis of N-heteroaroyl aminosaccharide derivatives as fibroblast growth factor 2 signaling modulators.
    Dong J; Yao S; Zhou X; Zhang L; Xu Y
    Chem Pharm Bull (Tokyo); 2010 Sep; 58(9):1210-5. PubMed ID: 20823601
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fully Synthetic Heparan Sulfate-Based Neural Tissue Construct That Maintains the Undifferentiated State of Neural Stem Cells.
    Chopra P; Logun MT; White EM; Lu W; Locklin J; Karumbaiah L; Boons GJ
    ACS Chem Biol; 2019 Sep; 14(9):1921-1929. PubMed ID: 31389687
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Functional abnormalities of heparan sulfate in mucopolysaccharidosis-I are associated with defective biologic activity of FGF-2 on human multipotent progenitor cells.
    Pan C; Nelson MS; Reyes M; Koodie L; Brazil JJ; Stephenson EJ; Zhao RC; Peters C; Selleck SB; Stringer SE; Gupta P
    Blood; 2005 Sep; 106(6):1956-64. PubMed ID: 15947088
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transport of fibroblast growth factor 2 in the pericellular matrix is controlled by the spatial distribution of its binding sites in heparan sulfate.
    Duchesne L; Octeau V; Bearon RN; Beckett A; Prior IA; Lounis B; Fernig DG
    PLoS Biol; 2012 Jul; 10(7):e1001361. PubMed ID: 22815649
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Startling Properties of Fibroblast Growth Factor 2: How to Exit Mammalian Cells without a Signal Peptide at Hand.
    La Venuta G; Zeitler M; Steringer JP; Müller HM; Nickel W
    J Biol Chem; 2015 Nov; 290(45):27015-27020. PubMed ID: 26416892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.